These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2900700)
1. Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines. Singh G; Luna MK; Ardalan B Cancer Chemother Pharmacol; 1988; 22(3):191-6. PubMed ID: 2900700 [TBL] [Abstract][Full Text] [Related]
2. Correlation of biochemical effects and incorporation of 3-deazaguanine into nucleic acids to cytotoxicity in L1210 cells. Pieper RO; Barrows LR; Mandel HG Cancer Res; 1986 Oct; 46(10):4960-5. PubMed ID: 3756857 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and mechanism of action of 6-thio-3-deazaguanine. Mian AM; Furusawa S Cancer Res; 1987 Apr; 47(7):1863-6. PubMed ID: 3815377 [TBL] [Abstract][Full Text] [Related]
4. Mode of action of 2-amino-6-chloro-1-deazapurine. Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712 [TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus. Hedstrom L; Cheung KS; Wang CC Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525 [TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of the adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase activities from Leishmania donovani. Allen T; Henschel EV; Coons T; Cross L; Conley J; Ullman B Mol Biochem Parasitol; 1989 Mar; 33(3):273-81. PubMed ID: 2704389 [TBL] [Abstract][Full Text] [Related]
7. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein. Munagala NR; Wang CC Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428 [TBL] [Abstract][Full Text] [Related]
9. Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells. Koyama H; Tsuji M Biochem Pharmacol; 1983 Dec; 32(23):3547-53. PubMed ID: 6140013 [TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of Lesch-Nyhan syndrome and some characteristics of hypoxanthine-guanine phosphoribosyltransferase and adenine phosphoribosyltransferase in human tissues and cultivated cells. Shin-Buehring YS; Osang M; Wirtz A; Haas B; Rahm P; Schaub J Pediatr Res; 1980 Jun; 14(6):825-9. PubMed ID: 7402756 [TBL] [Abstract][Full Text] [Related]
11. The changes in the levels of dihydrofolate reductase mRNA and its gene dosage in 5-fluorouracil-resistant L1210 cells. Konishi Y; Kanamaru R; Ishioka C; Ishikawa A; Shibata H; Wakui A; Dei T Tohoku J Exp Med; 1990 May; 161(1):33-42. PubMed ID: 2396254 [TBL] [Abstract][Full Text] [Related]
12. 3-Deazaguanine: inhibition of initiation of translation in L1210 cells. Rivest RS; Irwin D; Mandel HG Cancer Res; 1982 Oct; 42(10):4039-44. PubMed ID: 7105000 [TBL] [Abstract][Full Text] [Related]
13. Elucidation of aberrant purine metabolism: application to hypoxanthine-guanine phosphoribosylstransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts. Snyder FF; Trafzer RJ; Hershfield MS; Seegmiller JE Biochim Biophys Acta; 1980 Oct; 609(3):492-501. PubMed ID: 6108130 [TBL] [Abstract][Full Text] [Related]
14. The metabolism of 3-deazaguanine and 3-deazaguanosine by human cells in culture. Page TM; Jacobsen SJ; Nyhan WL; Mangum JH; Robins RK Int J Biochem; 1986; 18(10):957-60. PubMed ID: 2431931 [TBL] [Abstract][Full Text] [Related]
15. 3-Deazaguanosine is metabolized to the triphosphate derivative in Chinese hamster cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Saunders PP; Tan MT; Spindler CD; Robins RK; Plunkett W J Biol Chem; 1986 May; 261(14):6416-22. PubMed ID: 3700397 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and metabolic effects of 2-azahypoxanthine and 2-azaadenosine. Bennett LL; Smithers D; Rose LM; Adamson DJ; Shaddix SC; Thomas HJ Biochem Pharmacol; 1985 Apr; 34(8):1293-304. PubMed ID: 2859858 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line. Zoref-Shani E; Bromberg Y; Brosh S; Sidi Y; Sperling O J Neurochem; 1993 Aug; 61(2):457-63. PubMed ID: 8336135 [TBL] [Abstract][Full Text] [Related]